Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once vs twice daily corticosteroids and blood glucose in ANCA vasculitis
DRKS00018969Phase 4Recruiting
- Sponsor
- Universitätsklinik für Innere Medizin
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisolone in anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) (2 arms), sponsored by Universitätsklinik für Innere Medizin. Primary endpoint: Blood glucose profile by dosing schedule. Started Aug 2021; status: recruiting.
02
Drugs
prednisolone
03
Conditions
anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on DRKS00018969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00018969.